{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:10:14Z","timestamp":1678558214120},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1985,6,1]],"date-time":"1985-06-01T00:00:00Z","timestamp":486432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1985,6]]},"DOI":"10.1007\/bf00174165","type":"journal-article","created":{"date-parts":[[2004,8,15]],"date-time":"2004-08-15T13:54:35Z","timestamp":1092578075000},"page":"167-171","source":"Crossref","is-referenced-by-count":4,"title":["First-line combination chemotherapy with mitoxantrone and cyclophosphamide in advanced breast cancer"],"prefix":"10.1007","volume":"3","author":[{"given":"P.","family":"Periti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Robustelli","family":"Delia Cuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pannuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Martoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Mini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"BF00174165_CR1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0025-7125(16)31273-1","volume":"61","author":"CM Haskell","year":"1977","unstructured":"Haskell CM: Management of metastatic breast cancer. Med Clin N Am 61 (5):967\u2013978, 1977","journal-title":"Med Clin N Am"},{"key":"BF00174165_CR2","first-page":"329","volume":"36","author":"B Hoogstraten","year":"1975","unstructured":"Hoogstraten B: Adriamycin (NSC-123237) in the treatment of advanced breast cancer: studies by the Southwest Oncology Group. Cancer Chemother Rep 36:329\u2013334, 1975","journal-title":"Cancer Chemother Rep"},{"issue":"Suppl B","key":"BF00174165_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0305-7372(83)90017-8","volume":"10","author":"FM Schabel Jr","year":"1983","unstructured":"Schabel FM Jr, Corbett TH, Griswold DP Jr, Laster WR Jr, Trader MW: Therapeutic activity of mitoxantrone and ametantrone against murine tumors. Cancer Treat Rev 10 (Suppl B):13\u201321, 1983","journal-title":"Cancer Treat Rev"},{"key":"BF00174165_CR4","first-page":"179","volume":"8","author":"RC Stuart-Harris","year":"1982","unstructured":"Stuart-Harris RC, Smith IE: Mitoxantrone: a phase II study in the treatment of patients with advanced breast carcinoma and other solid tumors. Cancer Chemother Pharmacol 8:179\u2013182, 1982","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Suppl B","key":"BF00174165_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0305-7372(83)90021-X","volume":"10","author":"JA Neidhart","year":"1983","unstructured":"Neidhart JA, Gochonour D, Raach RW, Steinberg JA, Joung D: Mitoxantrone versus doxorubicin in advanced breast cancer: a randomized cross-over trial. Cancer Treat Rev 10 (Suppl B):41\u201346, 1983","journal-title":"Cancer Treat Rev"},{"issue":"Suppl B","key":"BF00174165_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0305-7372(83)90020-8","volume":"10","author":"IE Smith","year":"1983","unstructured":"Smith IE, Stuart-Harris RC, Pavlidis N, Bozek T: Mitoxantrone (Novantrone) as single agent and in combination chemotherapy in the treatment of advanced breast cancer. Cancer Treat Rev 10 (Suppl B):37\u201340, 1983","journal-title":"Cancer Treat Rev"},{"key":"BF00174165_CR7","first-page":"322","volume":"6","author":"L Hagerber","year":"1980","unstructured":"Hagerber L, Loymds P, Nagel GA: Mitoxantrone HCl, 1, 4-dihydroxy-5, 8-bis((2-((2-hydroxyethyl)amino)ethyl) amino)-9, 10-anthracenedione dihydrochloride. Ein neues zytostaticum. Onkologie 6:322\u2013328, 1980","journal-title":"Onkologie"},{"key":"BF00174165_CR8","first-page":"1516","volume":"40","author":"DD Von Hoff","year":"1980","unstructured":"Von Hoff DD, Pollard E, Kuhn J, Murray E, Coltman CA Jr: Phase I clinical investigation of 1, 4-dihydroxy-5, 8- bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione dihydrochloride (NSC No. 301739), a new anthracenedione. Cancer Res 40:1516\u20131518, 1980","journal-title":"Cancer Res"},{"issue":"Suppl B","key":"BF00174165_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0305-7372(83)90019-1","volume":"10","author":"RJ Crossley","year":"1983","unstructured":"Crossley RJ: Clinical safety and tolerance of mitoxantrone. Cancer Treat Rev 10 (Suppl B):29\u201336, 1983","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"BF00174165_CR10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-0142(197507)36:1<90::AID-CNCR2820360104>3.0.CO;2-H","volume":"36","author":"SE Jones","year":"1975","unstructured":"Jones SE, Durie BG, Salmon SE: Combination chemotherapy with Adriamycin and cyclophosphamide for advanced breast cancer. Cancer 36 (1):90\u201397, 1975","journal-title":"Cancer"},{"key":"BF00174165_CR11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/0002-9343(81)90541-6","volume":"70","author":"RB Weiss","year":"1981","unstructured":"Weiss RB, Henry JE, DeVita VJ: Multimodal treatment of primary breast cancer. Am J Med 70:844\u2013851, 1981","journal-title":"Am J Med"},{"key":"BF00174165_CR12","unstructured":"World Health Organization: WHO handbook for reporting results of cancer treatment. WHO offset publication, no. 48, Geneva, 1979"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00174165\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00174165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:53:17Z","timestamp":1678557197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00174165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,6]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,6]]}},"alternative-id":["BF00174165"],"URL":"https:\/\/doi.org\/10.1007\/bf00174165","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,6]]}}}